Alzheimers disease therapeutics (Janssen)

N/A

Report date: 2025/03/20 10:00:21
NME

Base Information

Drug NameAlzheimers disease therapeutics (Janssen)
Drug Alias NameAlzheimers disease therapeutics (Shionogi)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesShionogi & Co Ltd
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A